In 2025, the FDA inspected a single device company located in Delaware, according to the U.S. Food and Drug Administration (FDA).
This represented the smallest share of inspections by company type in Delaware, accounting for 2.9% of all FDA inspections conducted in the state that year.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
According to its website, the FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety and quality.
| Project Area | No Action Indicated | Voluntary Action Indicated | Official Action Indicated |
|---|---|---|---|
| Bioresearch Monitoring | 5 | 1 | — |
| Blood and Blood Products | 1 | — | — |
| Colors and Cosmetics Technology | 1 | — | — |
| Drug Quality Assurance | — | 4 | — |
| Food Composition, Standards, Labeling and Econ | 1 | — | — |
| Foodborne Biological Hazards | 14 | 2 | 1 |
| Human Cellular, Tissue, and Gene Therapies | 2 | — | — |
| Monitoring of Marketed Animal Drugs, Feed, and Devices | 2 | — | 1 |
